Cite
HARVARD Citation
Julsgaard, M. et al. (2021). Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study. Alimentary pharmacology & therapeutics. 54 (10), pp. 1320-1329. [Online].